Cardiovascular

Bivalirudin For Angioplasty: Expensive Heparin?

April 30, 2008
Source: American College of Cardiology Annual Meeting Chicago March 29-April1, 2008
Tony Gershlick
Tony Gershlick

Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the ACC annual meeting. Tony Gershlick and Adnan Kastrati discuss the study with Peter Goodwin and Sara Freeman.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

    • Gilles Montalescot The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels

  • Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY study

    • HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: ACUITY Trial, ACC.07 Scientific Session and i2 Innovations Summit. Presentation Number: 2414-5 Patients with

  • Bivalirudin in ACS: The Acuity Study Findings

    • Michael Lincoff, Cleveland Clilnic, Cleveland Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The full picture of how

    1. Please note they use halperin, the Chinese drug, in these procedures or a dangerous european alternative.

      Posted by Dr. Gupta | May 23, 2008, 12:35 pm

    2. thank you for your material

      Posted by Zheng zhenzhong | August 13, 2008, 2:23 pm

    Post a comment